Moses Q Wilks1, Scott M Knowles2, Anna M Wu2, Sung-Cheng Huang3. 1. Department of Biomathematics, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California; and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine the University of California-Los Angeles, Los Angeles, California Moses.Wilks@ucla.edu. 2. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine the University of California-Los Angeles, Los Angeles, California. 3. Department of Biomathematics, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California; and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine the University of California-Los Angeles, Los Angeles, California.
Abstract
UNLABELLED: Large-molecule tracers, such as labeled antibodies, have shown success in immuno-PET for imaging of specific cell surface biomarkers. However, previous work has shown that localization of such tracers shows high levels of heterogeneity in target tissues, due to both the slow diffusion and the high affinity of these compounds. In this work, we investigate the effects of subvoxel spatial heterogeneity on measured time-activity curves in PET imaging and the effects of ignoring diffusion limitation on parameter estimates from kinetic modeling. METHODS: Partial differential equations (PDE) were built to model a radially symmetric reaction-diffusion equation describing the activity of immuno-PET tracers. The effects of slower diffusion on measured time-activity curves and parameter estimates were measured in silico, and a modified Levenberg-Marquardt algorithm with Bayesian priors was developed to accurately estimate parameters from diffusion-limited data. This algorithm was applied to immuno-PET data of mice implanted with prostate stem cell antigen-overexpressing tumors and injected with (124)I-labeled A11 anti-prostate stem cell antigen minibody. RESULTS: Slow diffusion of tracers in linear binding models resulted in heterogeneous localization in silico but no measurable differences in time-activity curves. For more realistic saturable binding models, measured time-activity curves were strongly dependent on diffusion rates of the tracers. Fitting diffusion-limited data with regular compartmental models led to parameter estimate bias in an excess of 1,000% of true values, while the new model and fitting protocol could accurately measure kinetics in silico. In vivo imaging data were also fit well by the new PDE model, with estimates of the dissociation constant (Kd) and receptor density close to in vitro measurements and with order of magnitude differences from a regular compartmental model ignoring tracer diffusion limitation. CONCLUSION: Heterogeneous localization of large, high-affinity compounds can lead to large differences in measured time-activity curves in immuno-PET imaging, and ignoring diffusion limitations can lead to large errors in kinetic parameter estimates. Modeling of these systems with PDE models with Bayesian priors is necessary for quantitative in vivo measurements of kinetics of slow-diffusion tracers.
UNLABELLED: Large-molecule tracers, such as labeled antibodies, have shown success in immuno-PET for imaging of specific cell surface biomarkers. However, previous work has shown that localization of such tracers shows high levels of heterogeneity in target tissues, due to both the slow diffusion and the high affinity of these compounds. In this work, we investigate the effects of subvoxel spatial heterogeneity on measured time-activity curves in PET imaging and the effects of ignoring diffusion limitation on parameter estimates from kinetic modeling. METHODS: Partial differential equations (PDE) were built to model a radially symmetric reaction-diffusion equation describing the activity of immuno-PET tracers. The effects of slower diffusion on measured time-activity curves and parameter estimates were measured in silico, and a modified Levenberg-Marquardt algorithm with Bayesian priors was developed to accurately estimate parameters from diffusion-limited data. This algorithm was applied to immuno-PET data of mice implanted with prostate stem cell antigen-overexpressing tumors and injected with (124)I-labeled A11 anti-prostate stem cell antigen minibody. RESULTS: Slow diffusion of tracers in linear binding models resulted in heterogeneous localization in silico but no measurable differences in time-activity curves. For more realistic saturable binding models, measured time-activity curves were strongly dependent on diffusion rates of the tracers. Fitting diffusion-limited data with regular compartmental models led to parameter estimate bias in an excess of 1,000% of true values, while the new model and fitting protocol could accurately measure kinetics in silico. In vivo imaging data were also fit well by the new PDE model, with estimates of the dissociation constant (Kd) and receptor density close to in vitro measurements and with order of magnitude differences from a regular compartmental model ignoring tracer diffusion limitation. CONCLUSION: Heterogeneous localization of large, high-affinity compounds can lead to large differences in measured time-activity curves in immuno-PET imaging, and ignoring diffusion limitations can lead to large errors in kinetic parameter estimates. Modeling of these systems with PDE models with Bayesian priors is necessary for quantitative in vivo measurements of kinetics of slow-diffusion tracers.
Authors: Vania Kenanova; Tove Olafsen; Desiree M Crow; Gobalakrishnan Sundaresan; Murugesan Subbarayan; Nora H Carter; David N Ikle; Paul J Yazaki; Arion F Chatziioannou; Sanjiv S Gambhir; Lawrence E Williams; John E Shively; David Colcher; Andrew A Raubitschek; Anna M Wu Journal: Cancer Res Date: 2005-01-15 Impact factor: 12.701
Authors: R E Reiter; Z Gu; T Watabe; G Thomas; K Szigeti; E Davis; M Wahl; S Nisitani; J Yamashiro; M M Le Beau; M Loda; O N Witte Journal: Proc Natl Acad Sci U S A Date: 1998-02-17 Impact factor: 11.205
Authors: S M Larson; K S Pentlow; N D Volkow; A P Wolf; R D Finn; R M Lambrecht; M C Graham; G Di Resta; B Bendriem; F Daghighian Journal: J Nucl Med Date: 1992-11 Impact factor: 10.057
Authors: Jeffrey V Leyton; Tove Olafsen; Eric J Lepin; Scott Hahm; Karl B Bauer; Robert E Reiter; Anna M Wu Journal: Clin Cancer Res Date: 2008-11-15 Impact factor: 12.531
Authors: Aaron T Mayer; Arutselvan Natarajan; Sydney R Gordon; Roy L Maute; Melissa N McCracken; Aaron M Ring; Irving L Weissman; Sanjiv S Gambhir Journal: J Nucl Med Date: 2016-12-15 Impact factor: 10.057
Authors: Jimson W D'Souza; Harvey Hensley; Mohan Doss; Charles Beigarten; Michael Torgov; Tove Olafsen; Jian Q Yu; Matthew K Robinson Journal: J Nucl Med Date: 2016-08-18 Impact factor: 10.057
Authors: Scott M Knowles; Richard Tavaré; Kirstin A Zettlitz; Matthew M Rochefort; Felix B Salazar; Ziyue Karen Jiang; Robert E Reiter; Anna M Wu Journal: Clin Cancer Res Date: 2014-10-17 Impact factor: 12.531
Authors: Lagnojita Sinha; Yu Wang; Cynthia Yang; Altaz Khan; Jovan G Brankov; Jonathan T C Liu; Kenneth M Tichauer Journal: Sci Rep Date: 2015-02-26 Impact factor: 4.379
Authors: Tong Wang; Kai Yi Wu; Robert C Miner; Jennifer M Renaud; Rob S B Beanlands; Robert A deKemp Journal: EJNMMI Res Date: 2018-07-20 Impact factor: 3.138